Annals of Oncology is a leading medical oncology journal specializing in targeted therapies, immune treatments, personalized medicine, and molecular pathology. With over 48,500 followers, it disseminates cutting-edge research on genomic and immunophenotypic characteristics of cancers, including NSCLC and solid tumors, supporting clinical management and biomarker development. The journal emphasizes open-access publications to advance oncology knowledge globally.

‌